Sfoglia per Rivista
Sublingual immunotherapy in the treatment of adult allergic rhinitis patients
2006-01-01 Canonica, Giorgio; Passalacqua, Giovanni
Sublingual IT in OAS
2000-01-01 Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni
Sublingual or injection immunotherapy: the final answer?
2004-01-01 Passalacqua, G; Canonica, Gw
Sublingual swallow or spit?
2001-01-01 Passalacqua, Giovanni; Villa, G; Altrinetti, V; Falagiani, P; Canonica, Giorgio; Mariani, G; Bagnasco, Marcello
Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications
2001-01-01 Marcucci, F; Sensi, L; Frati, F; Senna, Ge; Canonica, Giorgio; Parmiani, S; Passalacqua, Giovanni
Successful combined therapy for refractory chronic urticaria in a 10-year-old boy
2004-01-01 Canonica, Giorgio; Passalacqua, Giovanni; Caminiti, L; Barberio, G; Pajno, Gb
Systemic contact dermatitis caused by corticosteroids in an asthmatic patient
2009-01-01 Bommarito, L; Nebiolo, F; Badiu, I; Guida, G; Heffler, E; Mietta, S; Rolla, G
Systemic reactions to peach are associated with high levels of specific IgE to Pru p 3
2009-01-01 Rossi, Re; Monasterolo, G; Canonica, Gw; Passalacqua, G
Terfenadine in allergic chronic cough in children
1992-01-01 Ciprandi, G; Tosca, Ma; Iudice, A; Buscaglia, S; Fasce, L; Canonica, Gw
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy
2013-01-01 Passalacqua, Giovanni; Melioli, G; Bonifazi, F; Bonini, S; Maggi, E; Senna, G; Triggiani, M; Nettis, E; Rossi, Re; Vacca, A; Canonica, Giorgio
The adhesion molecules of allergic inflammation: recent insights into their functional roles
1994-01-01 Canonica, G.; G, Ciprandi; S, Buscaglia; Gp, Pesce; M, Bagnasco
The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine
2004-01-01 Bousquet, J; Bindslev-Jensen, C; Canonica, Gw; Fokkens, W; Kim, H; Kowalski, M; Magnan, A; Mullol, J; van Cauwenberge, P
The clinical safety of H1-receptor antagonists. An EAACI position paper
1996-01-01 Passalacqua, Giovanni; Bousquet, J; Bachert, C; Church, Mk; Bindsley Jensen, C; Nagy, L; Szemere, P; Davies, Rj; Durham, Sr; Horak, F; Kontou Fili, K; Malling, Hj; van Cauwenberge, P; Canonica, Giorgio
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper
2009-01-01 Bousquet, Pj; Brozek, J; Bachert, C; Bieber, T; Bonini, S; Burney, P; Calderon, M; Canonica, Gw; Compalati, E; Daures, Jp; Delgado, L; Demoly, P; Dahl, R; Durham, Sr; Kowalski, Ml; Malling, Hj; Merk, H; Papadopoulos, N; Passalacqua, G; Simon, Hu; Worms, M; Wahn, U; Zuberbier, T; Schünemann, Hj; Bousquet, J
The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
2018-01-01 Zuberbier, T.; Aberer, W.; Asero, R.; Latiff A. H., Abdul; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C.; Ensina, L. F.; Gimenez-Arnau, A.; Godse, K.; Goncalo, M.; Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Katelaris, C. H.; Kocaturk, E.; Kulthanan, K.; Larenas-Linnemann, D.; Leslie, T. A.; Magerl, M.; Mathelier-Fusade, P.; Meshkova, R. Y.; Metz, M.; Nast, A.; Nettis, E.; Oude-Elberink, H.; Rosumeck, S.; Saini, S. S.; Sanchez-Borges, M.; Schmid-Grendelmeier, P.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Vestergaard, C.; Wedi, B.; Werner, R. N.; Maurer, M.
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings
2009-01-01 Młynek, A; Magerl, M; Hanna, M; Lhachimi, S; Baiardini, I; Canonica, Gw; Brzoza, Z; Kasperska-Zajac, A; Rogala, B; Zalewska-Janowska, A; Zuberbier, T; Maurer, M
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review
2008-01-01 Baiardini, I; Braido, Fulvio; Brandi, S; Tarantini, F; Bonini, S; Bousquet, Pj; Zuberbier, T; Demoly, P; Canonica, Giorgio
The role of patient training in the management of seasonal rhinitis and asthma: clinical implications
2001-01-01 Gani, F; Pozzi, E; Crivellaro, Ma; Senna, G; Landi, M; Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni
The safety of sublingual immunotherapy with one or more allergens in adults
2008-01-01 Lombardi, C; Gargioni, S; Cottini, M; Canonica, Giorgio; Passalacqua, Giovanni; Mar, A. L. L. E. R. G. Y.
THE SAFETY OF SUBLINGUAL IMMUNOTHERAPY WITH ONE OR MULTIPLE POLLEN ALLERGENS IN CHILDREN
2008-01-01 Agostinis, F; Landi, M; Cottini, M; Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Sublingual immunotherapy in the treatment of adult allergic rhinitis patients | 1-gen-2006 | Canonica, Giorgio; Passalacqua, Giovanni | |
Sublingual IT in OAS | 1-gen-2000 | Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni | |
Sublingual or injection immunotherapy: the final answer? | 1-gen-2004 | Passalacqua, G; Canonica, Gw | |
Sublingual swallow or spit? | 1-gen-2001 | Passalacqua, Giovanni; Villa, G; Altrinetti, V; Falagiani, P; Canonica, Giorgio; Mariani, G; Bagnasco, Marcello | |
Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications | 1-gen-2001 | Marcucci, F; Sensi, L; Frati, F; Senna, Ge; Canonica, Giorgio; Parmiani, S; Passalacqua, Giovanni | |
Successful combined therapy for refractory chronic urticaria in a 10-year-old boy | 1-gen-2004 | Canonica, Giorgio; Passalacqua, Giovanni; Caminiti, L; Barberio, G; Pajno, Gb | |
Systemic contact dermatitis caused by corticosteroids in an asthmatic patient | 1-gen-2009 | Bommarito, L; Nebiolo, F; Badiu, I; Guida, G; Heffler, E; Mietta, S; Rolla, G | |
Systemic reactions to peach are associated with high levels of specific IgE to Pru p 3 | 1-gen-2009 | Rossi, Re; Monasterolo, G; Canonica, Gw; Passalacqua, G | |
Terfenadine in allergic chronic cough in children | 1-gen-1992 | Ciprandi, G; Tosca, Ma; Iudice, A; Buscaglia, S; Fasce, L; Canonica, Gw | |
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy | 1-gen-2013 | Passalacqua, Giovanni; Melioli, G; Bonifazi, F; Bonini, S; Maggi, E; Senna, G; Triggiani, M; Nettis, E; Rossi, Re; Vacca, A; Canonica, Giorgio | |
The adhesion molecules of allergic inflammation: recent insights into their functional roles | 1-gen-1994 | Canonica, G.; G, Ciprandi; S, Buscaglia; Gp, Pesce; M, Bagnasco | |
The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine | 1-gen-2004 | Bousquet, J; Bindslev-Jensen, C; Canonica, Gw; Fokkens, W; Kim, H; Kowalski, M; Magnan, A; Mullol, J; van Cauwenberge, P | |
The clinical safety of H1-receptor antagonists. An EAACI position paper | 1-gen-1996 | Passalacqua, Giovanni; Bousquet, J; Bachert, C; Church, Mk; Bindsley Jensen, C; Nagy, L; Szemere, P; Davies, Rj; Durham, Sr; Horak, F; Kontou Fili, K; Malling, Hj; van Cauwenberge, P; Canonica, Giorgio | |
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper | 1-gen-2009 | Bousquet, Pj; Brozek, J; Bachert, C; Bieber, T; Bonini, S; Burney, P; Calderon, M; Canonica, Gw; Compalati, E; Daures, Jp; Delgado, L; Demoly, P; Dahl, R; Durham, Sr; Kowalski, Ml; Malling, Hj; Merk, H; Papadopoulos, N; Passalacqua, G; Simon, Hu; Worms, M; Wahn, U; Zuberbier, T; Schünemann, Hj; Bousquet, J | |
The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria | 1-gen-2018 | Zuberbier, T.; Aberer, W.; Asero, R.; Latiff A. H., Abdul; Baker, D.; Ballmer-Weber, B.; Bernstein, J. A.; Bindslev-Jensen, C.; Brzoza, Z.; Buense Bedrikow, R.; Canonica, G; Church, M. K.; Craig, T.; Danilycheva, I. V.; Dressler, C.; Ensina, L. F.; Gimenez-Arnau, A.; Godse, K.; Goncalo, M.; Grattan, C.; Hebert, J.; Hide, M.; Kaplan, A.; Kapp, A.; Katelaris, C. H.; Kocaturk, E.; Kulthanan, K.; Larenas-Linnemann, D.; Leslie, T. A.; Magerl, M.; Mathelier-Fusade, P.; Meshkova, R. Y.; Metz, M.; Nast, A.; Nettis, E.; Oude-Elberink, H.; Rosumeck, S.; Saini, S. S.; Sanchez-Borges, M.; Schmid-Grendelmeier, P.; Staubach, P.; Sussman, G.; Toubi, E.; Vena, G. A.; Vestergaard, C.; Wedi, B.; Werner, R. N.; Maurer, M. | |
The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings | 1-gen-2009 | Młynek, A; Magerl, M; Hanna, M; Lhachimi, S; Baiardini, I; Canonica, Gw; Brzoza, Z; Kasperska-Zajac, A; Rogala, B; Zalewska-Janowska, A; Zuberbier, T; Maurer, M | |
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review | 1-gen-2008 | Baiardini, I; Braido, Fulvio; Brandi, S; Tarantini, F; Bonini, S; Bousquet, Pj; Zuberbier, T; Demoly, P; Canonica, Giorgio | |
The role of patient training in the management of seasonal rhinitis and asthma: clinical implications | 1-gen-2001 | Gani, F; Pozzi, E; Crivellaro, Ma; Senna, G; Landi, M; Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni | |
The safety of sublingual immunotherapy with one or more allergens in adults | 1-gen-2008 | Lombardi, C; Gargioni, S; Cottini, M; Canonica, Giorgio; Passalacqua, Giovanni; Mar, A. L. L. E. R. G. Y. | |
THE SAFETY OF SUBLINGUAL IMMUNOTHERAPY WITH ONE OR MULTIPLE POLLEN ALLERGENS IN CHILDREN | 1-gen-2008 | Agostinis, F; Landi, M; Cottini, M; Lombardi, C; Canonica, Giorgio; Passalacqua, Giovanni |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile